Dezinamide
Based on 1 Customer Validation
Dezinamide (ADD94057) is an antiepileptic agent. Dezinamide binds to the voltage-sensitive sodium channel.
商品は「研究用試薬」です。人や動物の医療用・臨床診断用・食品用の製品ではありません。
研究用途以外に使用した場合、当社は一切の責任を負いかねます。
- 純度 : 99.47%
- CAS 番号: 91077-32-6
- 分子式: C11H11F3N2O2
- 分子量:260.21
-
保管条件:Powder -20°C, 3 years ; In solvent -80°C, 6 months , -20°C, 1 month
生物活性
製品説明
化学情報
-
CAS 番号 91077-32-6
-
性状 Solid
-
分子量 260.21
-
分子式 C11H11F3N2O2
-
Color White to off-white
-
SMILES
O=C(N1CC(C1)OC2=CC=CC(C(F)(F)F)=C2)N
-
別名
AHR11748; AN051; ADD94057
-
輸送条件
Room temperature in continental US; may vary elsewhere.
-
保管条件
Powder -20°C 3 years In solvent -80°C 6 months -20°C 1 month
溶剤 & 溶解度
体外:
DMSO : 100 mg/mL (384.30 mM; Need ultrasonic; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
濃度 (開始) × 体積 (開始) = 濃度 (終了) × 体積 (終了)
純度とドキュメンテーション
-
データシート (266 KB)
-
SDS (252 KB)
- English - EN (252 KB)
- Français - FR (252 KB)
- Deutsch - DE (252 KB)
- Norwegian - NO (252 KB)
- Español - ES (252 KB)
- Swedish - SV (252 KB)
- Italian - IT (252 KB)
- Korean - KR (252 KB)
- Portuguese - PT (252 KB)
-
取扱説明書 (2659 KB)
参考文献
[1]. Fisher R, et al. Clobazam, oxcarbazepine, tiagabine, topiramate, and other new antiepileptic drugs. Epilepsia. 1995;36 Suppl 2:S105-14. [Content Brief]
[2]. Privitera MD, et al. Dezinamide for partial seizures: results of an n-of-1 design trial. Neurology. 1994 Aug;44(8):1453-8. [Content Brief]
Complete Stock Solution Preparation Table
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
| Optional Solvent | Concentration Solvent Mass | 1 mg | 5 mg | 10 mg | 25 mg |
|---|---|---|---|---|---|
| DMSO | 1 mM | 3.8430 mL | 19.2152 mL | 38.4305 mL | 96.0762 mL |
| 5 mM | 0.7686 mL | 3.8430 mL | 7.6861 mL | 19.2152 mL | |
| 10 mM | 0.3843 mL | 1.9215 mL | 3.8430 mL | 9.6076 mL | |
| 15 mM | 0.2562 mL | 1.2810 mL | 2.5620 mL | 6.4051 mL | |
| 20 mM | 0.1922 mL | 0.9608 mL | 1.9215 mL | 4.8038 mL | |
| 25 mM | 0.1537 mL | 0.7686 mL | 1.5372 mL | 3.8430 mL | |
| 30 mM | 0.1281 mL | 0.6405 mL | 1.2810 mL | 3.2025 mL | |
| 40 mM | 0.0961 mL | 0.4804 mL | 0.9608 mL | 2.4019 mL | |
| 50 mM | 0.0769 mL | 0.3843 mL | 0.7686 mL | 1.9215 mL | |
| 60 mM | 0.0641 mL | 0.3203 mL | 0.6405 mL | 1.6013 mL | |
| 80 mM | 0.0480 mL | 0.2402 mL | 0.4804 mL | 1.2010 mL | |
| 100 mM | 0.0384 mL | 0.1922 mL | 0.3843 mL | 0.9608 mL |